What Happened
According to reports out of New Mexico, the parent company of that state’s largest electric utility and a major private equity firm have pushed back their proposed multibillion-dollar merger closing date to May 31, 2027. The extension came on the heels of a state regulatory ruling that allegedly found the two companies violated New Mexico law by completing a $400 million stock sale in 2025 without first securing approval from the New Mexico Public Regulation Commission (PRC).
Based on the reporting, the PRC imposed $300,000 in penalties, and the utility parent has reportedly taken out a $400 million loan to unwind the disputed stock transaction. The companies say they remain committed to the roughly $11.5 billion deal and continue to argue that it will benefit customers across New Mexico and Texas. No court has entered a final judgment on the underlying dispute, and the parties have publicly denied wrongdoing.
While the incident took place in New Mexico, the legal issues it raises — regulatory approval of corporate transactions, shareholder disclosures, fiduciary duties, and the enforceability of merger agreements — are directly relevant to Arizona business owners, investors, and executives who deal with regulated industries or large M&A transactions.
Who May Be Liable
When a corporate transaction allegedly proceeds without required regulatory sign-off, several categories of defendants may face exposure. In a matter like the one reported, the following parties could be liable depending on the facts developed in discovery:
- The regulated corporate parent that allegedly authorized or executed the transaction without the required approval.
- The acquiring investor or private equity sponsor, if it allegedly participated in or benefited from a transaction that violated state law.
- Officers and directors who approved the transaction, who may face fiduciary duty claims from shareholders or the corporation itself.
- Advisors and underwriters, including investment banks and law firms, if they allegedly failed to identify or disclose the regulatory approval requirement.
In Arizona, similar exposure could reach any Arizona-based utility, telecom, insurance carrier, healthcare system, cannabis operator, or other regulated business that closes a change-of-control transaction without notifying or obtaining sign-off from the Arizona Corporation Commission or another applicable state or federal regulator.
Legal Theories That May Apply
A fact pattern involving an alleged unapproved stock sale and a stalled merger can implicate several overlapping business and corporate law theories:
- Breach of fiduciary duty. Directors and officers owe duties of care and loyalty to the corporation and its shareholders. Approving a transaction that violates a known regulatory framework may be alleged to breach those duties.
- Breach of contract. Merger agreements typically contain representations, warranties, and covenants regarding regulatory compliance. An alleged violation could support a claim for breach or trigger material adverse change clauses.
- Securities disclosure claims. If disclosures to investors allegedly omitted the risk that the transaction required advance regulatory approval, shareholders may have federal and state securities claims.
- Regulatory and administrative penalties. State utility commissions, including Arizona’s, may impose fines, unwinding orders, or licensing consequences for transactions completed without approval.
- Shareholder derivative actions. Shareholders may be able to sue on behalf of the company to recover losses caused by allegedly wrongful conduct of insiders.
- Unjust enrichment or rescission claims. Parties who lost value or paid inflated prices in a transaction later deemed unlawful may seek to have the deal unwound or disgorged.
- Aiding and abetting. Advisors and counterparties who allegedly assisted in a knowing violation may face secondary liability.
Damages Victims May Recover
Business disputes rarely fit into a single damages bucket. Depending on the role of the claimant — shareholder, counterparty, minority investor, or the corporation itself — recoverable damages may include:
- Out-of-pocket financial losses, including declines in share value or the cost of unwinding a transaction (such as the $400 million refinancing reportedly used here).
- Lost profits or lost business opportunity, where the disruption or delay of a transaction causes measurable financial harm.
- Disgorgement of improper gains received by insiders or counterparties.
- Regulatory penalties and defense costs, which in some cases may be recoverable from directors, officers, or advisors under indemnification or D&O insurance frameworks.
- Rescission, meaning the unwinding of the disputed transaction.
- Attorneys’ fees and costs, where authorized by contract or statute.
- Punitive damages, in the rare cases where conduct is proven to be intentional, malicious, or grossly reckless under Arizona standards.
Arizona courts generally follow the business judgment rule, which protects good-faith decisions by directors — but that protection may weaken when a plaintiff shows an alleged knowing violation of law.
Evidence That Strengthens a Case
Corporate disputes are won and lost on the paper trail. If you believe you have been harmed by an unapproved or improperly disclosed transaction, key evidence typically includes:
- Board minutes, resolutions, and written consents relating to the transaction.
- Internal memos, emails, and Slack or Teams messages discussing regulatory strategy.
- Engagement letters and opinion letters from outside counsel, investment banks, and accountants.
- Regulatory filings, correspondence with commissions, and public orders (such as the PRC decision referenced in the reports here).
- Merger agreements, disclosure schedules, and side letters.
- Offering documents, proxy statements, and investor presentations.
- Analyst reports, trading data, and internal financial projections.
- Witness statements from insiders, former employees, or advisors familiar with the deal process.
What to Do Next
If you are an Arizona shareholder, joint venture partner, or business counterparty who believes you have been harmed by a transaction that allegedly skipped required regulatory review or was misrepresented to investors, protect yourself early:
- Preserve documents. Do not delete emails, texts, or files that relate to the transaction, even routine ones.
- Avoid unrepresented conversations. Do not give statements to opposing counsel, insurers, or regulators without your own attorney present.
- Track your damages. Keep contemporaneous records of financial losses, missed opportunities, and out-of-pocket costs.
- Mind the clock. Arizona has strict statutes of limitations for contract, fiduciary duty, and securities claims — waiting too long can eliminate otherwise strong claims.
- Get a confidential legal assessment. Every deal is different, and early strategic advice often shapes the outcome.
If you or your company has been affected by a corporate transaction that may have bypassed regulatory approval or misled investors, the team at Cardis Law Group is available to review the facts and explain your options. Reach out through cardislawgroup.com to schedule a confidential consultation with an Arizona business attorney.
Frequently Asked Questions
Can I sue a company if it closed a merger or stock sale without required regulatory approval?
Potentially, yes. If you are a shareholder, counterparty, or investor who suffered measurable financial harm because a transaction allegedly proceeded without required approval, you may have claims for breach of fiduciary duty, breach of contract, or securities violations. The specifics depend on your role and the governing agreements.
Does the Arizona Corporation Commission have to approve utility mergers?
Arizona regulates changes of control involving public service corporations, and certain transactions may require notice to or approval from the Arizona Corporation Commission. Whether a specific deal triggers that requirement depends on the entity involved and the structure of the transaction. An attorney can help evaluate the specific regulatory posture.
How long do I have to file a business or shareholder lawsuit in Arizona?
Deadlines vary by claim type. Written contract claims in Arizona generally have a six-year limitations period, while many tort-based claims — including some fiduciary duty and fraud claims — are shorter, often two or three years. Federal securities claims have their own strict deadlines, so early consultation is important.
What if I’m only a minority shareholder — do I still have rights?
Yes. Minority shareholders in Arizona corporations and LLCs have significant statutory and common-law rights, including the right to bring derivative actions, seek inspection of books and records, and challenge transactions that allegedly harm the company or unfairly benefit insiders.
Can directors and officers be personally liable for a deal that violated state law?
Potentially. While the business judgment rule protects many good-faith decisions, that protection may not apply where a plaintiff plausibly alleges that directors or officers knowingly approved a transaction that violated the law or breached their duty of loyalty. D&O insurance often plays a central role in these disputes.
What damages can my business recover if a deal collapses because of alleged regulatory violations?
Recoverable damages may include out-of-pocket losses, lost profits, financing and refinancing costs, disgorgement of improper gains, and in some cases rescission of the transaction. Where a contract or statute authorizes it, attorneys’ fees may also be recoverable.
Do I need to talk to regulators before I talk to a lawyer?
No. It is almost always better to consult with your own attorney first. Regulators serve the public interest, not your interest, and statements you make can be used in later proceedings. A lawyer can help you engage with regulators strategically and protect your rights.
How much does it cost to have Cardis Law Group review my situation?
Cardis Law Group offers confidential initial consultations for business and corporate matters. Fee arrangements vary depending on the complexity of the case, and in some matters alternative or contingency-based structures may be available.
Original reporting: kanw.org.